No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance

被引:18
作者
Groeneveld, D. J. [1 ]
van Bekkum, T. [1 ]
Cheung, K. L. [1 ]
Dirven, R. J. [1 ]
Castaman, G. [2 ]
Reitsma, P. H. [1 ]
van Vlijmen, B. [1 ]
Eikenboom, J. [1 ]
机构
[1] Leiden Univ, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, Med Ctr, NL-2300 RC Leiden, Netherlands
[2] Careggi Univ Hosp, Dept Heart & Vessels, Ctr Bleeding Disorders, Florence, Italy
关键词
ABO blood-group system; blood group antigens; type3; VWD; von Willebrand disease; von Willebrand factor; ENDOTHELIAL-CELLS; FACTOR-VIII; GROUP-A; PROPEPTIDE; DISEASE; PHARMACOKINETICS; PROTEOLYSIS; SURVIVAL; TRIAL; GENE;
D O I
10.1111/jth.12867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundOne of the major determinants of von Willebrand factor (VWF) plasma levels is ABO blood group status, and individuals with blood groupO have similar to 25% lower plasma levels. The exact mechanism behind this relationship remains unknown, although effects on clearance have been postulated. ObjectivesTo determine whether clearance of VWF is directly dependent on the presence of ABH antigens on VWF. MethodsThree type3 von Willebrand disease (VWD) patients were infused with Haemate-P, and the relative loading of VWF with ABH antigens at different time points was measured. VWF-deficient mice were injected with purified plasma-derived human VWF obtained from donors with either blood groupA, blood groupB, or blood groupO. ResultsIn mice, we found no difference in clearance rate between plasma-derived blood groupA, blood groupB and blood groupO VWF. Faster clearance of the blood groupO VWF present in Haemate-P infused in type3 VWD patients would have resulted in a relative increase in the loading of VWF with A and B antigens over time. However, we observed a two-fold decrease in the loading with A and B antigens in two out of three patients, and stable loading in the third patient. ConclusionThere is no direct effect of ABH antigens on VWF in VWF clearance. We demonstrate that, in a direct comparison within one individual, blood groupO VWF is not cleared faster than blood groupA or blood groupB VWF. Clearance differences between blood groupO and non-blood groupO individuals may therefore be related to the blood group status of the individual rather than the ABH antigen loading on VWF itself.
引用
收藏
页码:592 / 600
页数:9
相关论文
共 29 条
[1]   Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans [J].
Borchiellini, A ;
Fijnvandraat, K ;
tenCate, JW ;
Pajkrt, D ;
vanDeventer, SJH ;
Pasterkamp, G ;
MeijerHuizinga, F ;
ZwartHuinink, L ;
Voorberg, J ;
vanMourik, JA .
BLOOD, 1996, 88 (08) :2951-2958
[2]   Increased clearance of von Willebrand factor antigen post-DDAVP in type 1 von Willebrand disease: is it a potential pathogenic process? [J].
Brown, SA ;
Eldridge, A ;
Collins, PW ;
Bowen, DJ .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (08) :1714-1717
[3]   Clearance of von Willebrand factor [J].
Casari, C. ;
Lenting, P. J. ;
Wohner, N. ;
Christophe, O. D. ;
Denis, C. V. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 :202-211
[4]   VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease [J].
Eikenboom, Jeroen ;
Federici, Augusto B. ;
Dirven, Richard J. ;
Castaman, Giancarlo ;
Rodeghiero, Francesco ;
Budde, Ulrich ;
Schneppenheim, Reinhard ;
Batlle, Javier ;
Canciani, Maria Teresa ;
Goudemand, Jenny ;
Peake, Ian ;
Goodeve, Anne .
BLOOD, 2013, 121 (12) :2336-2339
[5]   Induction of Human Blood Group A Antigen Expression on Mouse Cells, Using Lentiviral Gene Transduction [J].
Fan, Xiaohu ;
Lang, Haili ;
Zhou, Xianpei ;
Zhang, Li ;
Yin, Rong ;
Maciejko, Jessica ;
Giannitsos, Vasiliki ;
Motyka, Bruce ;
Medin, Jeffrey A. ;
Platt, Jeffrey L. ;
West, Lori J. .
HUMAN GENE THERAPY, 2010, 21 (07) :877-890
[6]   A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor [J].
Gallinaro, Lisa ;
Cattini, Maria Grazia ;
Sztukowska, Maryta ;
Padrini, Roberto ;
Sartorello, Francesca ;
Pontara, Elena ;
Bertornoro, Antonella ;
Daidone, Viviana ;
Pagnan, Antonio ;
Casonato, Alessandra .
BLOOD, 2008, 111 (07) :3540-3545
[7]  
GILL JC, 1987, BLOOD, V69, P1691
[8]   Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival [J].
Haberichter, Sandra L. ;
Balistreri, Michael ;
Christopherson, Pamela ;
Morateck, Patricia ;
Gavazova, Stefana ;
Bellissimo, Daniel B. ;
Manco-Johnson, Marilyn J. ;
Gill, Joan Cox ;
Montgomery, Robert R. .
BLOOD, 2006, 108 (10) :3344-3351
[9]   SYNTHESIS OF ANTIHEMOPHILIC FACTOR ANTIGEN BY CULTURED HUMAN ENDOTHELIAL CELLS [J].
JAFFE, EA ;
HOYER, LW ;
NACHMAN, RL .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2757-2764
[10]   ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? [J].
Jenkins, P. Vince ;
O'Donnell, James S. .
TRANSFUSION, 2006, 46 (10) :1836-1844